Literature DB >> 17513552

Paradoxical embolus illustrating speed of action of recombinant tissue plasminogen activator in massive pulmonary embolism.

H Madani1, P A Ransom.   

Abstract

A case of a patient who presented with massive pulmonary embolism (PE) requiring thrombolysis with alteplase is reported. The subsequent presence of a patent foramen ovale and paradoxical embolism clinically demonstrated the speed of action of the recombinant tissue plasminogen activator. The advantage of this class of medication when considering the treatment options for a PE in an acute setting is highlighted.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17513552      PMCID： PMC2658293          DOI： 10.1136/emj.2006.045104

Source DB:  PubMed          Journal:  Emerg Med J        ISSN： 1472-0205            Impact factor:   2.740


  4 in total

Review 1.  Efficacy of thrombolytic agents in the treatment of pulmonary embolism.

Authors:  T Capstick; M T Henry
Journal:  Eur Respir J       Date:  2005-11       Impact factor: 16.671

2.  Peripheral ischemia caused by paradoxical embolization: an underestimated problem?

Authors:  Beate Hugl; Peter Klein-Weigel; Lydia Posch; Andreas Greiner; Gustav Fraedrich
Journal:  Mt Sinai J Med       Date:  2005-05

3.  Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.

Authors:  Stephan Windecker; Andreas Wahl; Krassen Nedeltchev; Marcel Arnold; Markus Schwerzmann; Christian Seiler; Heinrich P Mattle; Bernhard Meier
Journal:  J Am Coll Cardiol       Date:  2004-08-18       Impact factor: 24.094

4.  Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism.

Authors:  Francisco Martín; Pedro L Sánchez; Elizabeth Doherty; Pedro J Colon-Hernandez; Gabriel Delgado; Ignacio Inglessis; Nandita Scott; Judy Hung; Mary Etta E King; Ferdinando Buonanno; Zareh Demirjian; Michael de Moor; Igor F Palacios
Journal:  Circulation       Date:  2002-08-27       Impact factor: 29.690
  4 in total
  4 in total

Review 1.  Patent foramen ovale: anatomy, outcomes, and closure.

Authors:  Patrick A Calvert; Bushra S Rana; Anna C Kydd; Leonard M Shapiro
Journal:  Nat Rev Cardiol       Date:  2011-02-01       Impact factor: 32.419

2.  Individual lytic efficacy of recombinant tissue plasminogen activator in an in vitro human clot model: rate of "nonresponse".

Authors:  Jason M Meunier; Evan Wenker; Christopher J Lindsell; George J Shaw
Journal:  Acad Emerg Med       Date:  2013-05       Impact factor: 3.451

3.  A unique presentation of four thrombotic events at a time.

Authors:  Ali Raza Rajani; Kosar Hussain; Fahad Omar Baslaib; Ghazi Ahmad Radaideh
Journal:  BMJ Case Rep       Date:  2012-11-27

Review 4.  Patent Foramen Ovale Closure in 2019.

Authors:  Joel P Giblett; Omar Abdul-Samad; Leonard M Shapiro; Bushra S Rana; Patrick A Calvert
Journal:  Interv Cardiol       Date:  2019-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.